2020 News Briefs - International Neuromodulation Society

Earlier News:

Study Explores Cortical Plasticity from Transcranial Direct Current Stimulation

May 2020 - A crossover, blinded, sham-controlled study of 22 healthy volunteers assessed stimulus-specific effects of transcranial direct current stimulation on cortical plasticity. (Source: NeuroImage)

Ultrasound Stimulation Studied in Memory Loss

Feb. 11, 2020 - A small pilot study of 35 people with probable Alzheimer's disease tracked the patients' neuropsychological scores over three months following ultrasound brain stimulation sessions with transcranial pulse stimulation, designed to activate relatively deep parts of the brain and potentially support "neuroplastic regeneration of diseased brain functions". (Source: JAMA Network)

Stimulation Device for Obstructive Sleep Apnea Undergoes Multi-Center Study

Feb. 13, 2020 - An open-label, single-arm study, at centers in Australia, France, and the United Kingdom, evaluated safety and efficacy of a bilateral hypoglossal nerve stimulation device for treatment of obstructive sleep apnea. (Source: Healio)

Newspaper Profiles Man with Movement Disorder Who Received Neurostimulation Therapy

Feb. 13, 2020 - An article features a Parkinson's disease patient in Vancouver, B.C. whose function and quality of life improved after he received a deep brain stimulation system. (Source: Vancouver Sun)

Results Presented of Clinical Trial Using Evoked Compound Action Potentials to Adjust Spinal Cord Stimulation

Feb. 13, 2020 - The 12-month results of a randomized, double-blind trial of closed-loop spinal cord stimulation for chronic pain were reported during the annual scientific meeting of the North American Neuromodulation Society. (Source: NeuroNews)

Study Provides Preclinical Evidence of Brain Stimulation During Unconscious State

Feb. 12, 2020 - Researchers from the University of Wisconsin reported research in primates in which electrical brain stimulation to the central lateral thalamus was able to arose them from a deep unconscious state induced by deep anesthesia. (Source: Wisconsin State Journal)

Analysis Pools Evidence of Smoking in Spinal Cord Stimulation Patients

Jan. 28, 2020 - A review documents the prevalence of smoking in patients with spinal cord stimulators, which can adversely impact pain-related outcomes. (Source: Regional Anesthesia & Pain Medicine)

Case Study: Advice on Perioperative Management of Spinal Cord Stimulators

Feb. 10, 2020 - In the context of a case study, two co-authors present advice about the perioperative management of spinal cord stimulators (SCS) and implantable pulse generators to minimize the risk of the SCS losing functionality when patients undergo procedures for other issues. (Source: Pain Medicine)

Clinical Trial in Spain Concerns a Potential Visual Prosthetic that Stimulates the Visual Cortex

Feb. 6, 2020 - An article focused on the first participant of a clinical trial in Spain explains research there to develop a visual prosthetic system that provides visual information from an eye-gear-mounted camera system to the visual cortex. (Source: MIT Technology Review)

Researchers Pursue Development of a Stretchable Polymer Battery

Feb. 5, 2020 - A research lab at Stanford University is developing a solid, but stretchable, polymer battery that might be used in body-worn sensors or medical device applications. (Source: Today's Medical Developments)

Researchers Issue a Guide About Supervised Home Use of Transcranial Direct Current Stimulation

Feb. 10, 2020 - Researchers have produced a guide concerning the supervised use of transcranial direct current stimulation at home for clinical research and practice. (Source: Brain Stimulation)

Author Summarizes Status of Varied Deep Brain Stimulation Targets Studied in Treatment-Resistant Obsessive Compulsive Disorder

Feb. 10, 2020 - The status of deep brain stimulation (DBS) in refractory obsessive compulsive disorder (OCD), and descriptions and rationale regarding six stimulation targets, were covered in an overview article. The article states that fewer than 300 patients with OCD have had DBS, which in the U.S. received an FDA Humanitarian Device Exception clearance. The author notes that most of these patients receiving the treatment participate in clinical trials due to insurance coverage issues. (Source: Psychiatry Advisor)

Randomized Trial Compares Neurostimulation to Medical Treatment Alone in Patients with Advanced Parkinson's Disease

Feb. 7, 2020 - A paper presents 12-month results in a randomized trial in 25 patients with advanced Parkinson's disease that compared deep brain stimulation in the caudal zona incerta versus best medical treatment. (Source: Journal of Neurosurgery)

12-Month Results Published for Prospective, Open-Label Study of Closed Loop Spinal Cord Stimulation

Feb. 5, 2020 - A team of co-authors published 12-month results regarding 50 patients who were implanted with a closed-loop spinal cord stimulation system to treat chronic pain in a prospective, open-label study. (Source: Neurosurgery)

Parkinson's Disease Patient in Germany Receives Recently Approved Deep Brain Stimulation System

Feb. 6, 2020 - The neurosurgical department of the LMU University Hospital in Munich announced that in January it was the first center to implant a Parkinson's disease patient with a deep brain stimulation system, recently approved in the European Union, which records brain signals to personalize the therapy and optimize stimulation delivery. (Source: IDW)

Study: Glutamate as a Potential Biomarker of Response, in Patients with Depression, to Deep Brain Stimulation

April 2020 - In 16 patients with treatment-resistant depression, researchers measured baseline glutamate in the rostral anterior cingulate and checked if that was predictive of response at six months to deep brain stimulation to the subcallosal cingulate. (Source: Journal of Affective Disorders)

Annual Call for Award Applications Opens for Early-Stage Neuromodulation Investigators

February 2020 - The Science & PINS Prize is accepting applications by March 15, 2020 from junior investigators who have performed research in neuromodulation. The competition awards $25,000 and publishes the winner's research essay in the journal Science. The runner-up's essay is also published in Science. (Source: Science)

Noninvasive Brain Stimulation Study Explores Cortical Response

Jan. 31, 2020 - A study in healthy volunteers investigates how the physiological effects of noninvasive brain stimulation differ across the human cortex. (Source: Science Advances)

Multicenter Study Compares Medical Management and Spinal Cord Stimulation in Painful Diabetic Neuropathy

Feb. 4, 2020 - A presentation at the North American Neuromodulation Society (NANS) reported on an ongoing randomized controlled trial of spinal cord stimulation at 10kHz in painful diabetic neuropathy. (Source: NeuroNews)

Column Presents Neuromodulation as a Therapy Option to Manage Chronic Migraine

Feb. 4, 2020 - A column by a physician introduces neuromodulation as one recently emerging therapy option to help manage migraine, and suggests that patients could ask their physicians about different non-pharmaceutical treatments for migraine, since there are now a variety of options. The author says neuromodulation exemplifies the extent of progress being made in migraine management. (Yahoo! Lifestyle)

Heart Failure Neuromodulation Device Implanted in the United States

Feb. 3, 2020 - A medical center in New Jersey announced it is the first U.S. location to implant a neuromodulation device for congestive heart failure, Barostim Neo. (Source: Yahoo! Finance)

Researchers Investigate Brain Stimulation for Chronic Pain

Feb. 3, 2020 - Researchers began a clinical trial in October with funding from National Institutes of Health to directly observe how the brains of chronic pain patients represent their pain. The study may help to improve deep brain stimulation as a possible therapy for chronic pain, by potentially suggesting therapeutic neurostimulation targets and tracking neural response in order to automatically adjust stimulation levels. (Source: UCSF)

Documentary Features Functional Electrical Stimulation

Jan. 30, 2020 - A news story features the Cleveland FES Center, whose work creating functional electrical stimulation systems for people with functional deficits, such as quadriplegia, was included in the documentary "I Am Human". (Source: Freshwater Cleveland)

The Case for Establishing Neuromodulation Centers of Excellence

Jan. 30, 2020 - An opinion article by Robert Levy, MD, PhD, the President of the International Neuro­modulation Society and Editor-in-Chief of Neuromodulation: Technology at the Neural Interface, presents a strong case for establishing neuromodulation centers of excellence. (Source: Neuro News)

Following a Scientific Meeting, an Analyst Recaps Spinal Cord Stimulation Developments

Jan. 27, 2020 - An industry analyst provided an overview of developments from different spinal cord stimulation companies that were reported during the recent annual scientific meeting of the North American Neuromodulation Society (NANS). (Source: MD+DI)

Deep Brain Stimulation System Receives FDA Approval for an Additional Brain Target in Parkinson's Disease

Jan. 24, 2020 - Abbott announced the FDA has approved using its deep brain stimulation system to target the globus pallidus interna to manage medication-resistant motor symptoms of Parkinson's disease. (Source: MD+DI)

Study Results Presented Concerning Spinal Cord Stimulation in Chronic Pain

Jan. 23, 2020 - Abbott announced results presented at the North American Neuromodulation Society annual meeting about two prospective studies of its spinal cord stimulation system in people in chronic pain. (Biospace)

Device Maker Announces Scientific Presentations Concerning Its Spinal Cord Stimulation System

Jan. 22, 2020 - Nevro Corp. announced there will be a series of data presentations at the North American Neuromodulation Society annual meeting this week in Las Vegas concerning the company's spinal cord stimulation system for chronic pain. (Source: PR Newswire)

Company Begins Proof-of-Concept Studies in Human Subjects

Jan. 22, 2020 - Soin Neuroscience announced the start of early stage proof-of-concept studies in human subjects for the spinal cord stimulation device that the company is developing for chronic pain. (Source: P&T Community)

Company Announces Presentation of Spinal Cord Stimulation Studies

Jan. 21, 2020 - Saluda Medical Pty Limited announced that multiple studies of its spinal cord stimulation system for treatment of chronic pain will be presented during the annual meeting of the North American Neuromodulation Society. Neurology Advisor also published a summary of recent findings. (Source: PR Newswire)

Three-month Results Released from Randomized Controlled Trial Comparing Spinal Cord Stimulation Modes

Jan. 21, 2020 - Medtronic plc announced three-month results from a randomized controlled trial of differential target multiplexed spinal cord stimulation (SCS) compared to conventional SCS, adding that the results will be presented at the annual meeting of the North American Neuromodulation Society. (Source: Globe Newswire)

Case Series Published Concerning Peripheral Nerve Stimulation in Low Back Pain

Jan. 21, 2020 - SBR Therapeutics announced publication of a prospective case series concerning its peripheral nerve stimulation system in the treatment of low back pain. (Source: NeuroNews)

Research Center Formed by Universities in Australia and China

Jan. 15, 2020 - The University of Queensland in Australia and the Southern University of Science and Technology in China established a joint Centre for Neuroscience and Neural Engineering to formalize a partnership in which surgeons from Shenzhen had been trained in neuromodulation in Queensland. The collaboration will continue with research into neural protection and repair following stroke, and improved neuromodulation techniques for movement disorders and neurological conditions. (Source: University of Queensland)

Brain Study Suggests Basis of Essential Tremor and Potential Target for Neuromodulation

Jan. 15, 2020 - A study of structural differences in the brains of people with essential tremor suggests a brain-activity cause for the condition. The research could open possibilities to reduce tremor, potentially, for instance, with noninvasive types of neuromodulation using activity in that particular brain region as a guide, according to the paper's senior author. (Source: Columbia University Irving Medical Center)

Retrospective Article Considers Issues and Advances in Neurotechnology Development

January 2020 - A year-in-review column about developments in 2019 in the neurotechnology field identifies some challenges that have remained over the past decade concerning issues such as clinical trial design of control arms and obtaining reimbursement for emerging therapies. (Source: Neurotech Reports)

Column Discusses Non-Opioid Intrathecal Pain Relief

Jan. 14, 2020 - An opinion article discusses intrathecal ziconotide in the management of chronic non-cancer pain. (Source: Expert Opinion on Pharmacotherapy)

Researcher Analyzes Factors Influencing Development of Neural Interface Technologies

Jan. 8, 2020 - A viewpoint article discusses factors affecting translational research and development of neural technology, particularly, previously approved or emerging implantable devices and functional electrical stimulation systems. (Source: Neuron)

Company's Sacral Neuromodulation System Receives Marketing Clearance in Europe

Jan. 13, 2020 - Medtronic received CE mark clearance introduce its micro neurostimulator and leads for sacral neuromodulation therapy to treat overactive bladder, fecal incontinence, and non-obstrctive urinary retention. (Source: Medgadget)

CE Mark Announced for Deep Brain Stimulation System with Recording Capability

Jan. 9, 2020 - Medtronic has received CE mark approval in Europe for a deep brain stimulation system that can record brain signals. The company said the first implantations will begin next week in western Europe. (Source: Fierce Biotech)

Implantable Vagus Nerve Stimulation Generator is Subject to an FDA Recall in the United States

Dec. 23, 2019 - LivaNova is recalling its implantable vagus nerve stimulation SenTiva Generator System following reports of 14 reset errors that caused it to stop delivering therapy. Four patients required revision surgery to replace the generator. Since mitigation steps were taken July 31, the company said no additional reset errors were reported. The FDA identified the recall, initiated on Aug. 22, as Class I. Patients whose device resets, or who experience a loss of stimulation or an increase in symptoms, are advised to immediately contact a healthcare provide to determine if a replacement is needed. The recall affects 2,909 devices in the United States; the devices that failed did so within 60 days of the start of therapy, according to the FDA. (Source: MedTech Dive)

Device Company Acquires Developer of Differential Target Multiplexed Spinal Cord Stimulation

Jan. 9, 2020 - Medtronic announced it has acquired Stimgenics, a privately held company that developed differential target multiplexed spinal cord stimulation based on studies of neural-glial interactions. Three-month results of an ongoing randomized controlled trial in chronic pain are slated for presentation at the 23rd North American Neuromodulation Society annual meeting this month in Las Vegas. (Source: NeuroNews)

Neurostimulator Receives Marketing Approval in Europe for Treatment of Fecal Incontinence

Jan. 6, 2020 - BioNess announced it has received CE mark approval for its implantable tibial nerve stimulator for the treatment of fecal incontinence. (Source: Mass Device)

Television News Segment Features Clinical Trial of Neurostimulation as a Potential Treatment for Addiction

Jan. 6, 2020 - In a medical television news segment, a Pittsburgh, PA station featured the clinical trial of deep brain stimulation to the nucleus accumbens as an investigative potential therapy for treatment-resistant addiction. (Source: KDKA)

Workshop Invites Applicants to Explore Modeling and Simulation of Peripheral Neuromodulation to Regulate Organ Function

Jan. 1, 2020 - The IT'IS Foundation, with funding from the National Institutes of Health, is seeking applicants by Jan. 31 for a 5-day Ideas Lab in April to develop solutions for predictive modeling of peripheral neuromodulation to regulate organ function. (Source: SPARC Science)

Meta-Analysis Investigates Effectiveness of Placebo Vs. Spinal Cord Stimulation

Jan. 1, 2020 - A meta-analysis of spinal cord stimulation (SCS) trials introduces a potentially generalizable differentiation between placebo and sham concepts and investigates the effectiveness of SCS when compared with placebo. (Source: Pain)

Last Updated on Friday, February 14, 2020 03:35 PM